Association Between Schizophrenia-Related Polygenic Liability and the Occurrence and Level of Mood-Incongruent Psychotic Symptoms in Bipolar Disorder

Allardyce, J., Leonenko, G., Hamshere, M.L., Pardiñas, A., Forty, L., Knott, Sarah, Gordon-Smith, Katherine ORCID: https://orcid.org/0000-0003-4083-1143, Porteus, D., Haywood, C., Di Florio, A., Jones, Lisa ORCID: https://orcid.org/0000-0002-5122-8334, McIntosh, A., Owen, M., Holmans, P., Walters, J., Craddock, N., Jones, I., O'Donovan, M.C. and Escott-Price, V. (2018) Association Between Schizophrenia-Related Polygenic Liability and the Occurrence and Level of Mood-Incongruent Psychotic Symptoms in Bipolar Disorder. JAMA Psychiatry, 75 (1). pp. 28-35. ISSN Print: 2168-622X Online: 2168-6238

	Text Allardyce_A stratification study of bipolar disorder_accepted version post refereeing.docx - Accepted Version Restricted to Repository staff only Download (310kB) | Request a copy
Preview	Text Allardyce_A stratification study of bipolar disorder_accepted version post refereeing (1).pdf - Accepted Version Download (420kB) | Preview
Preview	Text jamapsychiatry_Allardyce_2017_oi_170083.pdf - Published Version Available under License Creative Commons Attribution. Download (443kB) | Preview

Abstract

Importance
Bipolar disorder (BD) overlaps schizophrenia in its clinical presentation and genetic liability. Alternative approaches to patient stratification beyond current diagnostic categories are needed to understand the underlying disease processes/mechanisms.
Objectives
To investigate the relationship between common-variant liability for schizophrenia, indexed by polygenic risk scores (PRS) and psychotic presentations of BD, using clinical descriptions which consider both occurrence and level of mood-incongruent psychotic features.
Design
Case-control design: using multinomial logistic regression, to estimate differential associations of PRS across categories of cases and controls.
Settings & Participants
4399 BD cases, 2966 (67%) female, mean age-at-interview 46 [sd 12] years, from the BD Research Network (BDRN) were included in the final analyses. For comparison genotypic data for 4976 schizophrenia cases and 9012 controls from the Type-1 diabetes genetics consortium and Generation Scotland were included.
Exposure
Standardised PRS, calculated using alleles with an association p-value threshold < 0.05 in the second Psychiatric Genomics Consortium genome-wide association study of schizophrenia, adjusted for the first 10 population principal components and genotyping-platform.
Main outcome measure
Multinomial logit models estimated PRS associations with BD stratified by (1) Research Diagnostic Criteria (RDC) BD subtypes (2) Lifetime occurrence of psychosis.(3) Lifetime mood-incongruent psychotic features and (4) ordinal logistic regression examined PRS associations across levels of mood-incongruence. Ratings were derived from the Schedule for Clinical Assessment in Neuropsychiatry interview (SCAN) and the Bipolar Affective Disorder Dimension Scale (BADDS).
Results
Across clinical phenotypes, there was an exposure-response gradient with the strongest PRS association for schizophrenia (RR=1.94, (95% C.I. 1.86, 2.01)), then schizoaffective BD (RR=1.37, (95% C.I. 1.22, 1.54)), BD I (RR= 1.30, (95% C.I. 1.24, 1.36)) and BD II (RR=1.04, (95% C.I. 0.97, 1.11)). Within BD cases, there was an effect gradient, indexed by the nature of psychosis, with prominent mood-incongruent psychotic features having the strongest association (RR=1.46, (95% C.I. 1.36, 1.57)), followed by mood-congruent psychosis (RR= 1.24, (95% C.I. 1.17, 1.33)) and lastly, BD cases with no history of psychosis (RR=1.09, (95% C.I. 1.04, 1.15)).
Conclusion
We show for the first time a polygenic-risk gradient, across schizophrenia and bipolar disorder, indexed by the occurrence and level of mood-incongruent psychotic symptoms.

Actions (login required)

View Item